These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1790547)

  • 1. Ofloxacin versus cephalexin in the treatment of skin, skin structure, and soft-tissue infections in adults.
    Powers RD; Schwartz R; Snow RM; Yarbrough DR
    Clin Ther; 1991; 13(6):727-36. PubMed ID: 1790547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative evaluation of oral ofloxacin versus intravenous cefotaxime therapy for serious skin and skin structure infections.
    Gentry LO; Rodriguez-Gomez G; Zeluff BJ; Khoshdel A; Price M
    Am J Med; 1989 Dec; 87(6C):57S-60S. PubMed ID: 2690621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ofloxacin versus cephalexin for treating skin and soft tissue infections.
    Lipsky BA; Yarbrough DR; Walker FB; Powers RD; Morman MR
    Int J Dermatol; 1992 Jun; 31(6):443-5. PubMed ID: 1512105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults.
    Giordano PA; Elston D; Akinlade BK; Weber K; Notario GF; Busman TA; Cifaldi M; Nilius AM
    Curr Med Res Opin; 2006 Dec; 22(12):2419-28. PubMed ID: 17257456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous fleroxacin versus ceftazidime for lower respiratory tract and skin and soft-tissue infections.
    Huston MJ; Lentino JR
    Clin Ther; 1992; 14(4):595-602. PubMed ID: 1525793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and laboratory studies with cefaclor: efficacy in skin and soft tissue infections.
    Dillon HC; Gray BM; Ware JC
    Postgrad Med J; 1979; 55 Suppl 4():77-81. PubMed ID: 548944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linezolid versus cefadroxil in the treatment of skin and skin structure infections in children.
    Wible K; Tregnaghi M; Bruss J; Fleishaker D; Naberhuis-Stehouwer S; Hilty M
    Pediatr Infect Dis J; 2003 Apr; 22(4):315-23. PubMed ID: 12690270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soft tissue infections in the emergency department: the case for the use of 'simple' antibiotics.
    Powers RD
    South Med J; 1991 Nov; 84(11):1313-5. PubMed ID: 1948213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxifloxacin versus cephalexin in the treatment of uncomplicated skin infections.
    Parish LC; Routh HB; Miskin B; Fidelholtz J; Werschler P; Heyd A; Haverstock D; Church D
    Int J Clin Pract; 2000 Oct; 54(8):497-503. PubMed ID: 11198726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with parenteral and oral ofloxacin in severe infections.
    Kanellakopoulou K; Giamarellou H
    Scand J Infect Dis Suppl; 1990; 68():64-9. PubMed ID: 2218425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical safety and efficacy of ofloxacin.
    Marone P; Concia E; Grossi P; Malfitano A; Perversi L
    Chemioterapia; 1988 Oct; 7(5):320-2. PubMed ID: 3224401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.
    Stryjewski ME; Graham DR; Wilson SE; O'Riordan W; Young D; Lentnek A; Ross DP; Fowler VG; Hopkins A; Friedland HD; Barriere SL; Kitt MM; Corey GR;
    Clin Infect Dis; 2008 Jun; 46(11):1683-93. PubMed ID: 18444791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
    Nicodemo AC; Robledo JA; Jasovich A; Neto W
    Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cephalexin: clinical effectiveness in geriatric patients.
    Smith IM
    Geriatrics; 1977 Mar; 32(3):91-5, 99. PubMed ID: 844692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children.
    Kaplan SL; Deville JG; Yogev R; Morfin MR; Wu E; Adler S; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB;
    Pediatr Infect Dis J; 2003 Aug; 22(8):677-86. PubMed ID: 12913766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clindamycin and cloxacillin compared in the treatment of skin and soft-tissue infections.
    Pusponegoro EH; Wiryadi BE
    Clin Ther; 1990; 12(3):236-41. PubMed ID: 2379228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of cefadroxil and cephalexin in children and adolescents with pyodermas. Cefadroxil Once Daily Pyoderma Study Group.
    Linder CW; Nelson K; Paryani S; Stallworth JR; Blumer JL
    Clin Ther; 1993; 15(1):46-56. PubMed ID: 8458054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the efficacy and safety of isepamicin and amikacin in the treatment of skin and skin structure infections.
    Rodriguez-Noriega E; Esparza-Ahumada S; Morfin-Otero R
    J Chemother; 1995 Jun; 7 Suppl 2():155-60. PubMed ID: 8622105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.